Envestnet Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $68.5M | Buy |
109,838
+686
| +0.6% | +$467K | 0.02% | 729 |
|
|
2026
Q1 | $84.3M | Buy |
109,152
+20,180
| +23% | +$15.4M | 0.02% | 590 |
|
|
2025
Q4 | $68.7M | Sell |
88,972
-12,589
| -12% | -$8.55M | 0.02% | 607 |
|
|
2025
Q3 | $57.1M | Sell |
101,561
-1,861
| -2% | -$1.05M | 0.02% | 718 |
|
|
2025
Q2 | $54.3M | Sell |
103,422
-13,305
| -11% | -$7.43M | 0.02% | 715 |
|
|
2025
Q1 | $74M | Buy |
116,727
+25,589
| +28% | +$17.6M | 0.02% | 562 |
|
|
2024
Q4 | $64.9M | Buy |
91,138
+10,060
| +12% | +$8.44M | 0.02% | 600 |
|
|
2024
Q3 | $85.2M | Buy |
81,078
+5,626
| +7% | +$6.26M | 0.03% | 524 |
|
|
2024
Q2 | $79.3M | Buy |
75,452
+8,209
| +12% | +$7.96M | 0.03% | 507 |
|
|
2024
Q1 | $64.7M | Buy |
67,243
+3,760
| +6% | +$3.58M | 0.02% | 569 |
|
|
2023
Q4 | $55.8M | Buy |
63,483
+5,794
| +10% | +$4.77M | 0.02% | 573 |
|
|
2023
Q3 | $47.5M | Sell |
57,689
-5,133
| -8% | -$4.03M | 0.02% | 595 |
|
|
2023
Q2 | $45.1M | Sell |
62,822
-1,853,952
| -97% | -$1.43B | 0.02% | 567 |
|
|
2023
Q1 | $50.5M | Buy |
1,916,774
+1,848,784
| +2,719% | +$1.39B | 0.02% | 501 |
|
|
2022
Q4 | $49.1M | Sell |
67,990
-10,152
| -13% | -$7.49M | 0.03% | 487 |
|
|
2022
Q3 | $53.8M | Buy |
78,142
+3,415
| +5% | +$2.15M | 0.03% | 419 |
|
|
2022
Q2 | $44.2M | Sell |
74,727
-5,003
| -6% | -$3.25M | 0.02% | 476 |
|
|
2022
Q1 | $55.7M | Sell |
79,730
-8,693
| -10% | -$5.5M | 0.03% | 451 |
|
|
2021
Q4 | $55.8M | Buy |
88,423
+20,763
| +31% | +$12.8M | 0.03% | 456 |
|
|
2021
Q3 | $40.9M | Buy |
67,660
+2,908
| +4% | +$1.81M | 0.02% | 527 |
|
|
2021
Q2 | $36.2M | Sell |
64,752
-10
| -0% | -$5.07K | 0.02% | 559 |
|
|
2021
Q1 | $30.6M | Buy |
64,762
+3,335
| +5% | +$1.62M | 0.02% | 566 |
|
|
2020
Q4 | $29.7M | Sell |
61,427
-561
| -0.9% | -$303K | 0.02% | 500 |
|
|
2020
Q3 | $34.7M | Sell |
61,988
-227
| -0.4% | -$138K | 0.03% | 397 |
|
|
2020
Q2 | $38.8M | Buy |
62,215
+6,278
| +11% | +$3.56M | 0.04% | 339 |
|
|
2020
Q1 | $27.3M | Buy |
55,937
+11,309
| +25% | +$4.66M | 0.03% | 365 |
|
|
2019
Q4 | $16.8M | Sell |
44,628
-442
| -1% | -$149K | 0.02% | 587 |
|
|
2019
Q3 | $12.5M | Sell |
45,070
-756
| -2% | -$224K | 0.01% | 657 |
|
|
2019
Q2 | $14.3M | Sell |
45,826
-3,701
| -7% | -$1.23M | 0.02% | 585 |
|
|
2019
Q1 | $20.3M | Sell |
49,527
-6,188
| -11% | -$2.55M | 0.03% | 445 |
|
|
2018
Q4 | $20.8M | Buy |
55,715
+54,624
| +5,007% | +$20M | 0.03% | 352 |
|
|
2018
Q3 | $441K | Sell |
1,091
-14,216
| -93% | -$5.41M | ﹤0.01% | 946 |
|
|
2018
Q2 | $5.28M | Sell |
15,307
-284
| -2% | -$88.8K | 0.01% | 480 |
|
|
2018
Q1 | $5.32M | Sell |
15,591
-7,264
| -32% | -$2.53M | 0.02% | 379 |
|
|
2017
Q4 | $8.59M | Sell |
22,855
-556
| -2% | -$225K | 0.02% | 429 |
|
|
2017
Q3 | $10.5M | Buy |
23,411
+95
| +0.4% | +$45.2K | 0.03% | 364 |
|
|
2017
Q2 | $11.4M | Buy |
23,316
+2,078
| +10% | +$909K | 0.03% | 337 |
|
|
2017
Q1 | $8.23M | Buy |
21,238
+5,264
| +33% | +$1.95M | 0.03% | 408 |
|
|
2016
Q4 | $5.86M | Buy |
15,974
+2,095
| +15% | +$797K | 0.02% | 489 |
|
|
2016
Q3 | $5.58M | Sell |
13,879
-2,925
| -17% | -$1.17M | 0.02% | 542 |
|
|
2016
Q2 | $5.87M | Sell |
16,804
-551
| -3% | -$212K | 0.02% | 562 |
|
|
2016
Q1 | $6.25M | Buy |
17,355
+1,245
| +8% | +$513K | 0.03% | 508 |
|
|
2015
Q4 | $8.75M | Buy |
16,110
+1,307
| +9% | +$708K | 0.04% | 393 |
|
|
2015
Q3 | $6.88M | Sell |
14,803
-1,975
| -12% | -$1.06M | 0.03% | 439 |
|
|
2015
Q2 | $8.56M | Sell |
16,778
-741
| -4% | -$362K | 0.04% | 422 |
|
|
2015
Q1 | $7.91M | Buy |
17,519
+16,106
| +1,140% | +$6.83M | 0.04% | 428 |
|
|
2014
Q4 | $580K | Sell |
1,413
-31
| -2% | -$12.2K | 0.01% | 678 |
|
|
2014
Q3 | $521K | Buy |
1,444
+13
| +0.9% | +$4.36K | 0.01% | 773 |
|
|
2014
Q2 | $404K | Buy |
1,431
+47
| +3% | +$13.9K | ﹤0.01% | 820 |
|
|
2014
Q1 | $416K | Buy |
1,384
+332
| +32% | +$102K | ﹤0.01% | 700 |
|
|
2013
Q4 | $290K | Buy |
1,052
+230
| +28% | +$66.2K | ﹤0.01% | 742 |
|
|
2013
Q3 | $257K | Buy |
822
+58
| +8% | +$15.3K | ﹤0.01% | 743 |
|
|
2013
Q2 | $172K | Buy |
+764
| New | +$178K | ﹤0.01% | 826 |
|
Other funds holding REGN
Envestnet Asset Management's REGN Position: Q2 2026 in Review
Envestnet Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 0.63% in Q2 2026, buying an estimated $467K and bringing the position to 109,838 shares worth $68.5M. The position accounts for 0.02% of the portfolio, ranked #729.
Envestnet Asset Management first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $85.2M in Q3 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Envestnet Asset Management held 109,838 shares of Regeneron Pharmaceuticals worth $68.5M as of Q2 2026.
- Envestnet Asset Management bought 686 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $467K.
- Regeneron Pharmaceuticals made up 0.02% of Envestnet Asset Management's portfolio in Q2 2026, its #729 holding.
- Envestnet Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Envestnet Asset Management's Regeneron Pharmaceuticals position peaked at $85.2M in Q3 2024.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.